These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 499400)

  • 1. Occurrence of mitochondrial monoamine oxidase in human semen.
    Suzuki O; Oya M; Katsumata Y; Matsumoto T; Yada S
    Experientia; 1979 Oct; 35(10):1289-90. PubMed ID: 499400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of brain mitochondrial monoamine oxidase by 6-hydroxydopamine.
    Youdim MB
    Br J Pharmacol; 1975 Jul; 54(3):403-5. PubMed ID: 1164597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study.
    Rao KS; Rao GV
    Mol Cell Biochem; 1994 Aug; 137(1):57-60. PubMed ID: 7845378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
    Naoi M; Nagatsu T
    Life Sci; 1987 Mar; 40(11):1075-82. PubMed ID: 3821373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical properties and kinetic parameters of monoamine oxydase in human seminal plasma.
    Roberge AG; Moufarege A; Lavoie J; Roberge C; Tremblay RR
    Int J Fertil; 1984; 29(3):180-5. PubMed ID: 6152258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase.
    Naoi M; Matsuura S; Parvez H; Takahashi T; Hirata Y; Minami M; Nagatsu T
    J Neurochem; 1989 Feb; 52(2):653-5. PubMed ID: 2911035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of synephrine by type A and type B monoamine oxidase.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y
    Experientia; 1979 Oct; 35(10):1283-4. PubMed ID: 499398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Properties of intestinal monoamine oxidase in the rat].
    Verevkina IV; Asnina VV; Gorkin VZ
    Vopr Med Khim; 1982; 28(2):88-93. PubMed ID: 7080482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat and human cardiac monoamine oxidase: a comparison with other tissues.
    Dial EJ; Clarke DE
    Eur J Pharmacol; 1979 Oct; 58(3):313-9. PubMed ID: 510362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RS-2232, a compound with a reversible and specific type-A monoamine oxidase inhibiting property in mouse brain.
    Yokoyama T; Iwata N; Kobayashi T
    Jpn J Pharmacol; 1987 Aug; 44(4):421-7. PubMed ID: 3682407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of monoamine oxidase (MAO) to the binding of tertiary basic drugs in lung mitochondria.
    Yoshida H; Kamiya A; Okumura K; Hori R
    Pharm Res; 1989 Oct; 6(10):877-82. PubMed ID: 2608630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of brain mitochondrial monoamine oxidases by the endogenous compound 5-hydroxyoxindole.
    Crumeyrolle-Arias M; Tournaire MC; Cane A; Launay JM; Barritault D; Medvedev A
    Biochem Pharmacol; 2004 Mar; 67(5):977-9. PubMed ID: 15104251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in monoamine oxidase activity in mouse brain associated with d-methamphetamine dependence and withdrawal.
    Egashira T; Yamanaka Y
    Biochem Pharmacol; 1993 Aug; 46(4):609-14. PubMed ID: 8363634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC-based bioactivity profiling of plant extracts: a kinetic assay for the identification of monoamine oxidase-A inhibitors using human recombinant monoamine oxidase-A.
    Dittmann K; Riese U; Hamburger M
    Phytochemistry; 2004 Nov; 65(21):2885-91. PubMed ID: 15501256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychoactive drug effects and substrate-specificity in intact mitochondrial monoamine oxidase from brain [proceedings].
    Gabay S; Achee FM
    Psychopharmacol Bull; 1977 Jan; 13(1):45-6. PubMed ID: 13452
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
    Shaik AN; LeDuc BW; Khan AA
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):827-834. PubMed ID: 28185143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.
    Baumanis EA; Kalnina IE; Moskvitina TA; Gorkin VZ
    Biochem Pharmacol; 1977 Jun; 26(11):1059-63. PubMed ID: 18152
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives.
    Minami M; Maruyama W; Dostert P; Nagatsu T; Naoi M
    J Neural Transm Gen Sect; 1993; 92(2-3):125-35. PubMed ID: 8369106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
    Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
    Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.